Markov Models in Non Metastatic Prostate Cancer – Availability of Input Factors and Structurural Uncertainty

Value in Health - United Kingdom
doi 10.1016/j.jval.2013.08.1652
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Apalutamide for the Treatment of Non‐metastatic Prostate Cancer

Prescriber
Pharmacology
2019English

Mp22-09 Association Between Androgen-Deprivation Therapy and Non-Prostate Cancer Mortality Among Men With Non-Metastatic Prostate Cancer

Journal of Urology
Urology
2018English

Quantifying Uncertainty in Transdimensional Markov Chain Monte Carlo Using Discrete Markov Models

Statistics and Computing
StatisticsProbabilityUncertaintyMathematicsComputational TheoryTheoretical Computer Science
2018English

STAMPEDE Trial and Patients With Non-Metastatic Prostate Cancer – Authors' Reply

The Lancet
Medicine
2016English

Prostate Cancer Predisposition Loci and Risk of Metastatic Disease and Prostate Cancer Recurrence

Clinical Cancer Research
Cancer ResearchOncology
2011English

MicroRNA-186 and Metastatic Prostate Cancer.

English

Combined Chemohormonalradiation Treatment of Highand Very-High-Risk Non-Metastatic Prostate Cancer

Onkourologiya
OncologyRadiologyUrologyNuclear MedicineNephrologyImagingSurgery
2017English

Expanding Horizons in Metastatic Prostate Cancer Treatment

Nature Reviews Clinical Oncology
Oncology
2011English

Clonal Origin and Spread of Metastatic Prostate Cancer

Endocrine-Related Cancer
Cancer ResearchEndocrinologyOncologyMetabolismDiabetes
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy